Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Isis Extends Timeline on Cholesterol-Lowering Drug, FDA Delays Review of Cadence Pain Reliever, Fate Therapeutics Raises $30 Million, & More San Diego Life Sciences News
|
Denise Gellene |
11/19/09 |
San Diego
|
|
A Week of Woe for Genzyme, A CPR App for Your iPhone, A Better Treatment for Opioid Dependence, and More Boston-Area Life Sciences News
|
Wade Roush |
11/19/09 |
Boston
|
|
Isis, Genzyme Cholesterol Drug Passes Test, But Investors Get Nervous About Liver Safety
|
Luke Timmerman |
11/17/09 |
San Diego
|
|
Isis Spinoff Altair Therapeutics Closes $17M Venture Round For Asthma Drug
|
Luke Timmerman |
11/12/09 |
San Diego
|
|
Altair Therapeutics Receives $17,000,000 New Financing Round
|
VentureDeal |
11/12/09 |
San Diego
|
|
Excaliard, an Isis Spinoff With Anti-Scarring Drug, Marches Ahead in Clinical Trials
|
Luke Timmerman |
10/29/09 |
San Diego
|
|
Santaris Nabs Isis, Amgen Vets
|
Luke Timmerman |
10/28/09 |
San Diego
|
|
Sequenom Settles Ibis Dispute
|
Luke Timmerman |
10/27/09 |
San Diego
|
|
Isis CEO Vows that Cholesterol Drug, Partnered With Genzyme, Will be “Remarkable” Advance
|
Luke Timmerman |
10/21/09 |
San Diego
|
|
Alnylam Chief Foresees Another Gene-Silencing Spin-Off, and More News Tidbits from Boston’s MassBio Investors Forum
|
Ryan McBride |
10/07/09 |
Boston
|
|
The San Diego Biotech Survival Index: Local Firms Make Strong Rebound In First Half of 2009
|
Luke Timmerman |
09/23/09 |
San Diego
|
|
Amylin Targets Obesity, Tioga Shows Virtual Business Model, Roka Bioscience Spins Off Gen-Probe, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
09/17/09 |
San Diego
|
|
MicroRNA Drug Developer Santaris Establishes Toehold in San Diego With Isis Veteran
|
Luke Timmerman |
09/16/09 |
San Diego
|
|
Qualcomm’s Snapdragon Chip Keeps Smartbooks “Always On,” Sapphire Energy Developing Bio-Refinery, EvoNexus Picks First Startups, & More San Diego BizTech News
|
Bruce V. Bigelow |
09/14/09 |
San Diego
|
|
Isis Prepares Novel Treatment for Lou Gehrig’s Disease, BrainCells Is Encouraged by New Drug for Depression, Inovio Raises $30M, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
08/06/09 |
San Diego
|
|
Isis, Genzyme Use Antisense to Go Where Many Drugs Fail—The Brain
|
Luke Timmerman |
08/05/09 |
San Diego
|
|
$50M for Helicon, Cytori Bulks Up, Avanir Awaits Trial Results, & More San Diego Life Sciences News
|
Eric Hal Schwartz |
07/30/09 |
San Diego
|
|
Alnylam and Isis’ Offspring, Regulus, Keeps Pushing on Biology’s ‘Bleeding Edge’
|
Luke Timmerman |
07/28/09 |
San Diego
|
|
OncoGenex Drug Helps Prostate Cancer Patients Live Longer in Small Study
|
Luke Timmerman |
05/30/09 |
Seattle
|
|
Genentech Veteran Takes Agios’ Helm, E8 and MIT Take on Navigenics, Genzyme’s Mipomersen Takes Next Step, Alnylam Takes Advantage of Tekmira Technology, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
05/28/09 |
Boston
|
|
Tekmira Tackles RNAi Delivery Challenge, With Alnylam, Roche Putting It to the Test
|
Luke Timmerman |
05/26/09 |
Seattle
|
|
Genzyme, Isis Cholesterol Drug Reaches Goal in Pivotal Study, Paving the Way to FDA
|
Luke Timmerman |
05/20/09 |
Boston
|
|
Genzyme Offers Glimpse at Growth Engine, New Drugs for High Cholesterol, Gaucher’s
|
Luke Timmerman |
05/07/09 |
Boston
|
|
Qualcomm and Broadcom Sign Patent Peace Treaty, A Green Day for San Diego (as in Algae, Not Rock n’ Roll), Corporate Crisis Hits Sequenom, & Other San Diego BizTech News
|
Bruce V. Bigelow |
05/04/09 |
San Diego
|
|
Acme Packet Packs Up Covergence, Thermo Buys Biolab, Q1 Was Kind to Mobile, & More Boston-Area Deals News
|
Rebecca Zacks |
05/01/09 |
Boston
|
|
Merck Makes GlycoFi Center of its Biogenerics Strategy, Biogen Says Tysabri Might Promote Remyelination, Stemgent Teams with Fate, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
04/30/09 |
Boston
|
|
Isis, Alnylam to Collaborate on Single-Stranded RNA Drugs; Deal Could Add Up to $31 Million to Isis’ Coffers
|
Wade Roush |
04/29/09 |
San Diego
|
|
The San Diego Biotech Survival Index 2: Clinging to Cash in the Downturn
|
Luke Timmerman |
03/20/09 |
San Diego
|
|
ImmunoGen Drug Nears Finish Line, Surface Logix Latches Onto $20M, Athenahealth CEO Bush Talks Stimulus, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
03/11/09 |
Boston
|
|
Vertex Puts up $375M for ViroChem, Nuance Finally Nabs Zi, Proteon Procures $38M, & More Boston-Area Deals News
|
Rebecca Zacks |
03/06/09 |
Boston
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
